Joseph P. Hagan founded GroundSwell Advisors LLC. Currently, he is President, Chief Executive Officer & Director at Regulus Therapeutics, Inc.
He is also on the board of Zosano Pharma Corp. and Aurinia Pharmaceuticals, Inc.
In the past Mr. Hagan held the position of Acting Chief Executive Officer at Unity Pharma, Head-Corporate Development at Amgen, Inc. and Managing Director at Amgen Ventures LLC (a subsidiary of Amgen, Inc.), Director at Accelerator Services Corp., Chief Financial & Business Officer, Executive VP at Orexigen Therapeutics, Inc. and Partner at GroundSwell Advisors LLC.
He received an MBA from Northeastern University and an undergraduate degree from the University of California San Diego.